Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancer

S Paltoglou, R Das, SL Townley, TE Hickey, GA Tarulli… - Cancer research, 2017 - AACR
… To test this hypothesis, we first evaluated the influence of GRHL2 … We validated a subset of
these biological associations. … There is an urgent requirement for novel strategies that inhibit …

[HTML][HTML] Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives

KC Bulusu, R Guha, DJ Mason, RPI Lewis… - Drug discovery today, 2016 - Elsevier
… The rational discovery of novel drug combinations can be … novel and unexpected synergistic
drug combinations 19, 39. … assist in generating biologically meaningful MOA hypotheses for …

[HTML][HTML] A QSP model of prostate cancer immunotherapy to identify effective combination therapies

R Coletti, L Leonardelli, S Parolo, L Marchetti - Scientific reports, 2020 - nature.com
… to support drug development, by generating hypotheses that can be tested experimentally in
pre-… known biological mechanisms. We identify the most effective treatment combinations for …

[HTML][HTML] Alzheimer's disease, and breast and prostate cancer research: Translational failures and the importance to monitor outputs and impact of funded research

F Pistollato, C Bernasconi, J McCarthy, I Campia… - Animals, 2020 - mdpi.com
… , and design novel therapeutic and preventive strategies. … The current drug development
pipeline still strongly relies on … is based on experimental hypotheses formulated during basic/…

[HTML][HTML] Artificial intelligence in cancer target identification and drug discovery

Y You, X Lai, Y Pan, H Zheng, J Vera, S Liu… - … and Targeted Therapy, 2022 - nature.com
… to identify novel anticancer targets and discover drugs. … based on the experimentally
validated hypothesis that can … used the differentially expressed proteins of prostate cancer (PC…

Darolutamide maintenance in patients with metastatic castration-resistant prostate cancer with nonprogressive disease after taxane treatment (SAKK 08/16)

S Gillessen, G Procopio, S Hayoz, E Kremer… - Journal of Clinical …, 2023 - ascopubs.org
… treatment could be a novel strategy in managing patients … This prior trial had an early close,
owing to drug development … should be regarded rather as hypothesis-generating. They must …

Biological evolution of castration-resistant prostate cancer

A Davies, V Conteduca, A Zoubeidi, H Beltran - European Urology Focus, 2019 - Elsevier
… We review the biology of advanced prostate cancer, and highlight opportunities and challenges
for using biological or molecular assays to help guide individualized treatment decisions …

[HTML][HTML] Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer

D Chakravarty, SS Nair, N Hammouda… - … biology, 2020 - nature.com
… While these hypotheses are currently less well … drugs and novel vaccines to combat
SARS-CoV-2 infection, as well as repurposed drugs that could have an impact on prostate cancer

[HTML][HTML] Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ

W Al-Jameel, X Gou, X Jin, J Zhang, Q Wei, J Ai… - … & cancer, 2019 - ncbi.nlm.nih.gov
… the biological activity of FABP5, the availability of highly effective inhibitors to FABP5 is
an important first step in testing this hypothesis. … In this work, we have used the novel bio-inhibitor …

[图书][B] PAK4-Nampt Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors

GB Mpilla - 2021 - search.proquest.com
… more importantly the pursuit of understanding biological complexities. In our laboratory…
hypothesis was that targeting both PAK4 and NAMPT could become a synthetic lethal strategy for